| Literature DB >> 25565845 |
Jee Young Kwon1, Preeyaporn Koedrith2, Young Rok Seo1.
Abstract
Engineered nanoparticles (NPs) are widely used in many sectors, such as food, medicine, military, and sport, but their unique characteristics may cause deleterious health effects. Close attention is being paid to metal NP genotoxicity; however, NP genotoxic/carcinogenic effects and the underlying mechanisms remain to be elucidated. In this review, we address some metal and metal oxide NPs of interest and current genotoxicity tests in vitro and in vivo. Metal NPs can cause DNA damage such as chromosomal aberrations, DNA strand breaks, oxidative DNA damage, and mutations. We also discuss several parameters that may affect genotoxic response, including physicochemical properties, widely used assays/end point tests, and experimental conditions. Although potential biomarkers of nanogenotoxicity or carcinogenicity are suggested, inconsistent findings in the literature render results inconclusive due to a variety of factors. Advantages and limitations related to different methods for investigating genotoxicity are described, and future directions and recommendations for better understanding genotoxic potential are addressed.Entities:
Keywords: carcinogenicity; exposure assessment; genotoxicity; nanoparticles; risk evaluation
Mesh:
Substances:
Year: 2014 PMID: 25565845 PMCID: PMC4279763 DOI: 10.2147/IJN.S57918
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Various states of nanoparticles in different forms of dry powder and liquid in suspension media.
Genotoxicity studies of ZnO and silica nanoparaticles using in vitro and in vivo mammalian models
| Nanoparticles | Toxicological effect | Reference | |
|---|---|---|---|
| ZnO | Genotoxicity in vivo | Using in vivo micronucleus test, no genotoxic effect was observed in lung cells from rats exposed to triethozycaprylylsilane-coated ZnO by inhalation | Landsiedel et al |
| 50 nm ZnO had not induced micronucleus in the animal model at a concentration of up to 5 g/kg body weight | Li et al | ||
| 60–200 nm ZnO did not induce genotoxicity in the in vivo system | Monteiro-Riviere et al | ||
| Genotoxicity in vitro | Genotoxic potential was observed in ZnO exposed cells by alkaline standard comet assay | Gopalan et al | |
| Using comet assay, significant DNA damage was induced by 30 nm ZnO in a dose-dependent manner | Sharma et al | ||
| Induction of DNA damage was observed significantly in 10 nm and 20 nm ZnO exposure of Caco-2 cells with and without Fpg enzyme | Gerloff et al | ||
| Significant DNA damage was observed in 19.6±5.8 nm at 5 μg/mL and 10 μg/mL | Yang et al | ||
| Water-soluble ZnO nanoparticles have no mutagenic potential in Ames test | Yoshida et al | ||
| Diemthyoxydiphenylsilane/triethoxycaprylylsilane crosspolymer-coated ZnO was evaluated as nongenotoxic substance in Ames test | Landsiedel et al | ||
| Genotoxicity was observed by comet assay and micronucleus test in HEp-2 cells exposed to ZnO | Osman et al | ||
| Poly methyl acrylic acid coated ZnO induced significantly increased genotoxicity compared with uncoated ZnO measured by micronucleus test in WIL2-NS human lymphoblastoid cells | Yin et al | ||
| A significant increase in DNA damage was observed in 30 nm ZnO exposed cells | Sharma et al | ||
| 30 nm ZnO nanoparticles induced DNA damage in in vitro system | Sharma et al | ||
| DNA damage measuring by comet assay was observed in human nasal mucosa exposed to ZnO repetitively | Hackenberg et al | ||
| Oxidative stress | Poly methyl acrylic acid-coated ZnO showed decreased cytotoxicity and ROS generation compared with uncoated ZnO in WIL2-NS human lymphoblastoid cells | Yin et al | |
| ZnO induced mitochondrial dysfunction, morphological modification, and apoptosis in human fetal lung fibroblast | Zhang et al | ||
| ZnO led to cellular oxidant injury, inflammation, and cell death in in vitro system | Xia et al | ||
| Oxidative stress and cytotoxicity were induced by ZnO in human colon carcinoma cells | De Berardis et al | ||
| ZnO induced oxidative DNA damage and ROS-mediated apoptosis in human liver cells | Sharma et al | ||
| Induction of oxidative stress, DNA damage, and apoptosis were observed in a malignant human skin melanoma cell line exposed to ZnO | Alarifi et al | ||
| ZnO induced ROS-mediated cytotoxic effect in rat retinal ganglion cells | Guo et al | ||
| Silica | Genotoxicity in vivo | No induction of hypoxanthine phosphoribosyltransferase-encoding gene (HPRT) mutation frequency was observed in rats exposed to silica for 13 weeks | Johnston et al |
| Inhalation of 37 nm and 83 nm SiO2 did not induce genotoxicity in rat lung | Sayes et al | ||
| Genotoxicity in vitro | A weak induction of micronuclei was observed in V79 cells at highly cytotoxic doses | Liu et al | |
| No mutagenic potential was observed in Ames test with and without metabolic activation | ECETOC, | ||
| Also, no induction of chromosomal aberrations was observed in mammalian cells | EPA, | ||
| No induction of genotoxicity was detected by comet assay in mouse fibroblasts exposed to silica | Barnes et al | ||
| A very slight DNA damage was observed in silica-exposed primary mouse embryo fibroblast cells by comet assay | Yang et al | ||
| No significant induction of genotoxicity was observed in A549 cells exposed to amorphous silica particles for 40 hours | Gonzalez et al | ||
| Significant increase of micronuclei was induced in mouse fibroblast cells exposed to 80 nm silica nanoparticles | Park et al | ||
| Oxidative stress | SiO2 induced cytotoxicity via production of oxidative stress in human embryonic kidney cells | Wang et al | |
| P53 and Bax-mediated apoptosis was induced by SiO2 exposure in human hepatic cell line | Ye et al | ||
| P53 and p21-mediated G1 phase arrest was observed in myocardial cells | Ye et al | ||
| Endocytosis-dependent ROS generation and DNA damage was induced by nanosilica in human keratinocytes | Nabeshi et al | ||
| 20 nm silica induced cytotoxic effects via induction of ROS and lipid peroxidation in kidney cells | Passagne et al | ||
| Nanosized silica induced developmental neurotoxicity via production of oxidative stress in PC12 cells | Wang et al | ||
| Hepatotoxicity was induced by SiO2 in Kupffer cells | Chen et al | ||
| SiO2 led to cutaneous toxicity via ROS generation | Park et al |
Abbreviations: ROS, reactive oxygen species; SiO2, silicon dioxide; ZnO, zinc oxide.
Figure 2Scheme illustrating possible routes of cellular uptake, including passive diffusion, receptor-related endocytosis, and clarthrin- or caveolae-dependent endocytosis. In brief, nanoparticles are in the correct size and shape. They may dock on membrane receptors, facilitating receptor-mediated endocytosis. Alternatively, clathrin- or caveolae-mediated endocytosis may occur, which results in the formation of pits in the region of 120 nm or up to 80 nm, respectively, which regulates the size of the material they are able to enclose.
Figure 3Key indirect mechanisms underlying nanogenotoxicity. Nanoparticles (NPs) may cause oxidative stress induction, inflammatory responses, or aberrant cellular signaling. These responses may be implicated in cancer risk.
Abbreviations: NPs, nanoparticles; ROS, reactive oxygen species.
Figure 4Putative mechanisms underlying the detrimental effects of zinc oxide and silica nanoparticles. These nanoparticles dissolve in the extracellular milieu, giving rise to increased extracellular metallic cations. This leads to increased intracellular respective metallic cations, resulting in decreased activity of particular enzymes and transcription factors. Moreover, this event can induce ROS generation and resulting oxidative stress, as well as stimulate various cytokine production and inflammatory responses. These phenomena, in turn, render membrane damage, DNA breakage, mitochondrial dysfunction, and lysosome destabilization.
Abbreviations: ROS, reactive oxygen species; RNS, reactive nitrogen species; IL, interleukin; TNF, tumor necrosis factor; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; MAPK, mitogen-activated protein kinases; AP-1, activator protein 1.